Invasive fungal infections ‐ infections of the bloodstream and organs within the body (e.g. meningitis, pneumonia, peritonitis) ‐ are important causes of morbidity and mortality in liver, pancreas, heart, kidney and lung (i.e. solid organ) transplant recipients. This review found that fluconazole, used as a preventive drug, significantly reduced the number of invasive fungal infections in liver transplant patients. More studies are needed to determine how effective antifungal drugs are for pancreas, heart, kidney and lung transplant patients.
- organ transplant recipients
- antifungal agents
Playford, E. G., Webster, A. C., Craig, J. C., & Sorrell, T. C. (2004). Antifungal agents for preventing fungal infections in solid organ transplant recipients. Cochrane Database of Systematic Reviews, 2004(3), [CD004291]. https://doi.org/10.1002/14651858.CD004291.pub2